» Articles » PMID: 38606657

Dietary Sodium and Fluid Intake in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC

Abstract

Sodium and fluid restriction has traditionally been advocated in patients with heart failure (HF) due to their sodium and water avid state. However, most evidence regarding the altered sodium handling, fluid homeostasis and congestion-related signs and symptoms in patients with HF originates from untreated patient cohorts and physiological investigations. Recent data challenge the beneficial role of dietary sodium and fluid restriction in HF. Consequently, the European Society of Cardiology HF guidelines have gradually downgraded these recommendations over time, now advising for the limitation of salt intake to no more than 5 g/day in patients with HF, while contemplating fluid restriction of 1.5-2 L/day only in selected patients. Therefore, the objective of this clinical consensus statement is to provide advice on fluid and sodium intake in patients with acute and chronic HF, based on contemporary evidence and expert opinion.

Citing Articles

Guideline for the Use of Natriuretic Peptides in the Early Diagnosis and Management of Heart Failure in Primary Care .

Celik A, Ozturk G, Cavusoglu Y, Ardic C, Nalbantgil S, Arica S Balkan Med J. 2025; 42(2):94-107.

PMID: 40033605 PMC: 11881534. DOI: 10.4274/balkanmedj.galenos.2025.2024-12-110.


Nutritional and Nutraceutical Support to the Failing Myocardium: A Possible Way of Potentiating the Current Treatment of Heart Failure.

Macri R, Mollace R, Serra M, Scarano F, Ritorto G, Ussia S Int J Mol Sci. 2024; 25(22).

PMID: 39596298 PMC: 11594499. DOI: 10.3390/ijms252212232.


Unsupervised learning-derived phenotypes for personalized fluid management in critically ill patients with heart failure: A multicenter study.

Guan C, Gong A, Zhao Y, Yu H, Zhang S, Xie Z Clin Transl Med. 2024; 14(11):e70081.

PMID: 39514235 PMC: 11546239. DOI: 10.1002/ctm2.70081.


Sodium Zirconium Cyclosilicate for Renin-Angiotensin-Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis.

Williams R, Ford W, James A, Thomas K, Wong A Cardiol Ther. 2024; 13(4):797-809.

PMID: 39485602 PMC: 11607300. DOI: 10.1007/s40119-024-00388-z.


Targeting Sodium in Heart Failure.

Triposkiadis F, Xanthopoulos A, Skoularigis J J Pers Med. 2024; 14(10).

PMID: 39452570 PMC: 11508519. DOI: 10.3390/jpm14101064.